S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder|
|Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts (2014/12/16)|
|PFIZER REPORTS THIRD-QUARTER 2014 RESULTS|
|Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform|
|Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy|
|Pfizer Completes Acquisition of Baxter’s Marketed Vaccines|
|Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults|
|Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII|
|Pfizer's stock drops after profit outlook cut|
|Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia|
Click above to view more mutual fund data and stats for pfizer - Pfizer Ltd.